发明授权
US07674792B2 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
失效
5(Z)-5-(6-喹喔啉亚甲基)-2- [2,6-二氯苯基]氨基] -1,3-噻唑-4(5H) - 酮
- 专利标题: 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
- 专利标题(中): 5(Z)-5-(6-喹喔啉亚甲基)-2- [2,6-二氯苯基]氨基] -1,3-噻唑-4(5H) - 酮
-
申请号: US11726741申请日: 2007-03-22
-
公开(公告)号: US07674792B2公开(公告)日: 2010-03-09
- 发明人: Kevin J. Duffy , Duke M. Fitch , Beth A. Norton
- 申请人: Kevin J. Duffy , Duke M. Fitch , Beth A. Norton
- 申请人地址: US PA Philadelphia
- 专利权人: GlaxoSmithKline LLC
- 当前专利权人: GlaxoSmithKline LLC
- 当前专利权人地址: US PA Philadelphia
- 代理商 Wayne J. Dustman; Edward R. Gimmi; Charles M. Kinzig
- 主分类号: A61K31/498
- IPC分类号: A61K31/498 ; C07D417/06
摘要:
Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6 -dichlorophenyl)amino]-1,3-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of preparing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.